🔎 Trials Near Me

Acasă › Crize convulsive › North Carolina

Studii clinice pentru Crize convulsive în North Carolina

11 studii pentru Crize convulsive caută participanți în North Carolina.

Orașe în North Carolina

Text oficial al studiului (în engleză)

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

  • Atrium Health STRIVE Research, Charlotte
  • On-Site Clinical Solution, Charlotte
  • Duke University Medical Center, Durham
  • și încă 1
În curs de recrutareFaza 3
Vârste de la 2 la 55 · Toate sexele · Actualizat 2 oct. 2026 · NCT05066217

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Onsite Clinical Solutions, Charlotte
  • Velocity Clinical Research at Raleigh Neurology, Raleigh
În curs de recrutareFaza 1
Vârste de la 12 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07233239

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  • Asheville Neurology Specialists, Asheville
  • OnSite Clinical Solutions, LLC, Charlotte
În curs de recrutareFaza 2
Vârste de la 18 la 70 · Toate sexele · Actualizat 1 oct. 2026 · NCT06798896

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  • Asheville Neurology Specialists, Asheville
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 1 oct. 2026 · NCT07563881

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

  • Duke University Health System, Durham
  • Science 37, Morrisville
  • Wake Forest Baptist Medical Center, Winston-Salem
În curs de recrutareFaza 3
Vârste de 2 ani și peste · Toate sexele · Actualizat 15 sept. 2026 · NCT04462770

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

  • Velocity Clinical Research, Raleigh
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 sept. 2026 · NCT07594119

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Atrium Health, Charlotte
  • Duke University Hospital, Durham
  • Atrium Wake Forest Baptist, Winston-Salem
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 9 iun. 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • Duke University Clinic, Durham
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 mai 2026 · NCT05716100

Oxygen Toxicity: Mechanisms in Humans

  • Duke University Health Sustem, Durham
În curs de recrutareVoluntari sănătoși bineveniți
Vârste de la 18 la 45 · Toate sexele · Actualizat 23 oct. 2025 · NCT05761756

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • Mecklenburg EMS, Charlotte
În curs de recrutareFaza 3
6 Months – 13 Years · Toate sexele · Actualizat 30 sept. 2025 · NCT05121324

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  • Duke University Clinical Research at Pickett Road, Durham
În curs de recrutareFaza 3
Vârste de la 4 la 55 · Toate sexele · Actualizat 24 iul. 2025 · NCT05219617

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.